Valo Health, Inc.
12 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Integral Health, Inc. (to 2020)
2
Ending by 2030
Dec 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 25, 2026The maintenance fee for Novel Compounds and Compositions for the Inhibition of Nampt (US 10,329,275) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
- 1 fee due Jan 16, 2027The maintenance fee for Pyrrolotriazinones and Imidazotriazinones as Ubiquitin-Specific Protease 7 Inhibitors (US 10,351,571) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
- 5 fees due Feb 6 to 13, 2027 · next Feb 6
- 4 fees due Mar 10 to 24, 2027 · next Mar 10
- 7 fees due Apr 1 to 29, 2027 · next Apr 1
- 4 fees due May 5 to 19, 2027 · next May 5
- 15 fees due Jun 3 to 30, 2027 · next Jun 3
- 1 fee due Jul 21, 2027The maintenance fee for Methods Using HDAC11 Inhibitors (US 10,538,496) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for 2-Spiro-5- and 6-Hydroxamic Acid Indanes as Hdac Inhibitors (US 10,555,935) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
- 1 fee due Sep 5, 2027The maintenance fee for Bicyclic Compounds Useful as GPR120 Modulators (US 11,919,891) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.
- 1 fee due Nov 12, 2027The maintenance fee for Novel Compounds and Compositions for the Inhibition of Nampt (US 10,647,695) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 24, 2026
- Aug 26 US 7,577,553 Method and Apparatus for Molecular Mechanics Analysis of Molecular Systems · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,702,467 | Molecular Property Modeling Using Ranking In force · High confidence | In force | High confidence | |
| US 8,232,283 | Raf Inhibitors In force · Medium confidence | In force | Medium confidence | |
| US 8,450,348 | Derivatives of Squaric Acid with Anti-Proliferative Activity In force · High confidence | In force | High confidence | |
| US 9,169,209 | Novel Compounds and Compositions for the Inhibition of Nampt In force · High confidence | In force | High confidence | |
| US 10,272,072 | Novel Compounds and Compositions for the Inhibition of Nampt In force · High confidence | In force | High confidence | |
| US 10,329,275 | Novel Compounds and Compositions for the Inhibition of Nampt In force · High confidence | In force | High confidence | |
| US 10,456,382 | Novel Compounds and Compositions for the Inhibition of Nampt In force · Medium confidence | In force | Medium confidence | |
| US 10,647,695 | Novel Compounds and Compositions for the Inhibition of Nampt In force · High confidence | In force | High confidence | |
| US 10,772,874 | Novel Compounds and Compositions for the Inhibition of Nampt In force · Medium confidence | In force | Medium confidence | |
| US 11,279,687 | Novel Compounds and Compositions for the Inhibition of Nampt In force · High confidence | In force | High confidence |
Also on record, not counted in the 103: 12 patents in force now held by others · 1 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 5 abandoned · 3 no status recorded